S-metolachlor in pre-emergence reduces the leaf cuticular wax and increases the efficiency of glyphosate.

Background: The low glyphosate uptake capacity, possibly due to the lipophilic character of epicuticular wax on leaves, may contribute to the natural tolerance of some weed species. The use of pre-emergence herbicides like S-metolachlor, which inhibits very-long-chain fatty acid synthesis, might enhance glyphosate's post-emergent efficacy against hard-to-control weeds, such as Euphorbia heterophylla L. (milkweed) and Ipomoea triloba L.

Advances on polymeric nanocarriers for sustainable agriculture: Enhancing dsRNA/siRNA delivery to combat agricultural pests.

The application of exogenous RNA for gene-silencing strategies has gained significant traction in agriculture, offering a highly efficient and eco-friendly alternative to conventional plant protection methods. This success has been driven by advances in biotechnology, from the design of long double-stranded RNA (dsRNA) and small interfering RNA (siRNA) molecules to the development of nanocarrier systems that address the challenge of RNA delivery into plant cells. In particular, polymer-based nanocarriers have emerged as a promising solution for enhancing the stability and delivery efficiency of RNA molecules.

Molecular Markers for Analyses of Genetic Diversity within the Complex with Emphasis on Argentine Populations.

The South American fruit fly (Wiedmann) has a vast range extending from northern Mexico, through Central America, to South America where it is an extremely polyphagous pest of wild and cultivated fruits. It is a complex of cryptic species currently composed of eight recognised morphotypes: "Mexican", "Venezuelan", "Andean", "Peruvian", "Ecuadorian", and the three Brazilian morphotypes "Brazilian-1", "Brazilian-2", and "Brazilian-3". Molecular markers that can identify the member species of the complex are crucial for the implementation of effective pest control measures, such as the sterile insect technique.

From Illness to Resilience: Mediating Factors of Quality of Life in Patients with Congenital Heart Disease.

Background: Congenital heart disease (CHD) is a leading cause of childhood morbidity, with an estimated prevalence of 0.8-1%. However, advances in diagnosis and treatment now allow 90% of childhood CHD patients to survive to adulthood, leading to increased interest in their quality of life (QoL).